Literature DB >> 3553232

High levels of antibodies to streptococcal cell membrane antigens specifically bound to monoclonal antibodies in acute poststreptococcal glomerulonephritis.

M Yoshimoto, S Hosoi, S Fujisawa, M Sudo, R Okuda.   

Abstract

We produced 15 immunoglobulin G class monoclonal antibodies against antigens of the streptococcal cell membrane (SCM) of Streptococcus pyogenes (T type 12, Tanaka strain) and determined the levels in human sera of antibodies against Triton-X-extracted antigens specifically bound to each of these 15 monoclonal antibodies by enzyme-linked immunosorbent assay. Sample sera were obtained from 10 normal controls (group 1), 10 patients with streptococcal pharyngitis without sequelae (group 2), and 8 patients with acute poststreptococcal glomerulonephritis (APSGN) (group 3). Anti-streptolysin O (ASO) titers of the sera increased in the order of groups 1, 2, and 3. There was no relationship between ASO titer and the level of anti-SCM antibodies, and there was no significant difference in the level of anti-SCM antibodies determined with each of the 15 monoclonal antibodies between group 1 and group 2 sera. Group 3 sera had higher levels of antibodies to SCM antigens specifically bound to each of 14 of these 15 monoclonal antibodies than group 1 or group 2 sera did. Of these 14 monoclonal antibodies, 9 reacted with the four SCM antigens separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrophoretically transferred to a nitrocellulose sheet. These results suggest that high levels of antibodies to SCM antigens are related to the development of APSGN and that the systemic immune response to SCM antigens is involved in the pathogenesis of APSGN.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553232      PMCID: PMC266059          DOI: 10.1128/jcm.25.4.680-684.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Type-specific streptococcal antibody.

Authors:  F W DENNY; W D PERRY; L W WANNAMAKER
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

2.  Quantitative immunoelectrophoretic analysis of Streptococcus pyogenes membrane.

Authors:  R E Kessler; I van de Rijn
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

3.  Identification of streptococcal groups A,B,C, and G by slide co-agglutination of antibody-sensitized protein A-containing staphylococci.

Authors:  G Hahn; I Nyberg
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Partial characterization of antigenic streptococcal plasma membrane components in acute glomerulonephritis.

Authors:  G Treser; M Semar; A Ty; I Agel; M A Franklin; K Lange
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

6.  A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G.

Authors:  G Kronvall
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

7.  The role of streptococci in human glomerulonephritis.

Authors:  J B Zabriskie
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

8.  Production of group C streptococcus phage-associated lysin and the preparation of Streptococcus pyogenes protoplast membranes.

Authors:  J Wheeler; J Holland; J M Terry; J D Blainey
Journal:  J Gen Microbiol       Date:  1980-09

9.  The role of glycoprotein carbohydrate in the immunological reactivity of antistreptococcal cell-membrane and antiglomerular basement-membrane antisera.

Authors:  W T Blue; C F Lange; G Agostino; K Chase; A S Markowitz
Journal:  J Med Microbiol       Date:  1980-05       Impact factor: 2.472

10.  Isolation of heart- and kidney-binding protein from group A streptococci.

Authors:  M W Stinson; E J Bergey
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.